These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2565839
1. Pharmacological basis for the use of nimodipine in central nervous system disorders. Scriabine A, Schuurman T, Traber J. FASEB J; 1989 May; 3(7):1799-806. PubMed ID: 2565839 [Abstract] [Full Text] [Related]
2. Pharmacological influences on cardiopulmonary arrest-related brain damage in the rat. Calle PA. Verh K Acad Geneeskd Belg; 1993 May; 55(2):123-44. PubMed ID: 8480449 [Abstract] [Full Text] [Related]
3. Local nimodipine application improves early functional recovery in the rabbit hippocampus after 15-min global cerebral ischemia. Lazarewicz JW, Pluta R, Puka M, Salińska E. Acta Neurobiol Exp (Wars); 1993 May; 53(4):499-510. PubMed ID: 8109259 [Abstract] [Full Text] [Related]
4. Pharmacology of nimodipine. A review. Scriabine A, van den Kerckhoff W. Ann N Y Acad Sci; 1988 May; 522():698-706. PubMed ID: 3288065 [Abstract] [Full Text] [Related]
5. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Dreier JP, Windmüller O, Petzold G, Lindauer U, Einhäupl KM, Dirnagl U. Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352 [Abstract] [Full Text] [Related]
8. Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. Hakim AM. J Cereb Blood Flow Metab; 1986 Dec; 6(6):676-83. PubMed ID: 3793803 [Abstract] [Full Text] [Related]
9. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025 [Abstract] [Full Text] [Related]
10. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia]. Liu XG, Feng YP. Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015 [Abstract] [Full Text] [Related]
13. Nimodipine decreases calcium action potentials in rabbit hippocampal CA1 neurons in an age-dependent and concentration-dependent manner. Moyer JR, Disterhoft JF. Hippocampus; 1994 Feb; 4(1):11-7. PubMed ID: 8061749 [Abstract] [Full Text] [Related]
14. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. Germano IM, Bartkowski HM, Cassel ME, Pitts LH. J Neurosurg; 1987 Jul; 67(1):81-7. PubMed ID: 3598674 [Abstract] [Full Text] [Related]
15. Divergent neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca2+ homeostasis in dementia. Fischhof PK. Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):549-55. PubMed ID: 7794292 [Abstract] [Full Text] [Related]
16. [Effect of calcium antagonist nimodipine and induced hypertension on cerebral vessel reactivities, cerebral blood flow, cerebral edema and infarction in cats with one hour middle-cerebral-artery occlusion]. Sakaki T, Ishida T, Sasaoka Y, Thunoda S, Utsumi S. No Shinkei Geka; 1990 May; 18(5):423-30. PubMed ID: 2385317 [Abstract] [Full Text] [Related]
17. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow. Carmody J, Lilly JK. W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232 [Abstract] [Full Text] [Related]
18. In vivo binding of nimodipine in the brain: I. The effect of focal cerebral ischemia. Hakim AM, Hogan MJ. J Cereb Blood Flow Metab; 1991 Sep; 11(5):762-70. PubMed ID: 1874808 [Abstract] [Full Text] [Related]
19. In vivo binding of nimodipine in the brain: II. Binding kinetics in focal cerebral ischemia. Hogan MJ, Gjedde A, Hakim AM. J Cereb Blood Flow Metab; 1991 Sep; 11(5):771-8. PubMed ID: 1874809 [Abstract] [Full Text] [Related]